situ hibridizasyon yöntemi i - Çukurova Üniversitesi

129. Carless MA, Griffiths LR. Cytogenetics of melanoma and nonmelanoma skin cancer. Adv Exp
Med Biol. 2008; 624:227–240
130. Casorzo L, Luzzi C, Nardacchione A, Picciotto F, Pisacane A, Risio M.Fluorescence in situ
hybridization (FISH) evaluation of chromosomes 6, 7, 9 and 10 throughout human melanocytic
tumorigenesis. Melanoma Res. 2005; 15(3):155–160.
131. Diamond, M Mabry, D W Ball at al L medullary thyroid carcinomas.in the differentiation
response to Ras in human Mol. Cell. Biol. 1996; 16(10):5335
132. Mark R. Miglarese,2 Ruth Halaban, and Neil W. Gibson, Regulation of Fibroblast Growth
Factor 2 Expression in Melanoma Cells by the c-MYB Proto-Oncoprotein’Department of Cancer,
Immunology and Infectious Dıeases, Pfizer Central Research, Groton, Connecticut 06340 [M. R.
M., N. W. G.], and Department of Dermatology, Yale University School of Medicine, New Haven,
Connecticut Vol. 8, November 1997: 1199-1210,
133. Hosokawa, Y., and Arnold, A. Cyclin D1/PRAD1 as a central target in oncogenesis. J. Lab. Clin.
Med, 1996; 127: 246–252,
134. Maki Yamaura at al, Specific Dermoscopy Patterns and Amplifications of the Cyclin D1 Gene
to Define Histopathologically Unrecognizable Early Lesions of Acral Melanoma In Situ; Arch
Dermatol, 2005; 141:1413-1418
135. Willeke Am M Blokx at al, 3 Molecular cytogenetics of cutaneous melanocytic lesions –
diagnostic, prognostic and therapeutic aspects Histopathology 56, 2010; 121–132
136. Yazdi AS et al. Mutations of the BRAF gene in benign and malignant melanocytic lesions. J
Invest Dermatol. 2003; 121(5):1160–1162
137. Battayani Z et al. Polymerase chain reaction detection of circulating melanocytes as a prognostic
marker in patients with melanoma. Arch Dermatol. 1995; 131:443-447.
138. Foss AJ et al. The detection of melanoma cells in peripheral blood by reverse transcriptionpolymerase
chain reaction. Br J Cancer, 1995; 72:155-159.
139. Bostick PJ et al. Prognostic significance of occult metastases detected by sentinel
lymphadenectomy and reverse transcriptasepolymerase chain reaction in early-stage melanoma
patients. J Clin Oncol. 1999; 17:3238-3244.
140. Davids V at al, Melanoma patient staging: histopathological versus molecular evaluation of the
sentinel node. Melanoma Res 2003; 13: 313–324.
141. Jeuken JW at al, Comparative genomic hybridization: practical guidelines. Diagn. Mol. Pathol.
2002; 11:193–203
101